• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

七年之痒:2017年的全面分析干扰化合物(PAINS)——效用与局限

Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations.

作者信息

Baell Jonathan B, Nissink J Willem M

机构信息

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.

School of Pharmaceutical Sciences, Nanjing Tech University , No. 30 South Puzhu Road, Nanjing 211816, People's Republic of China.

出版信息

ACS Chem Biol. 2018 Jan 19;13(1):36-44. doi: 10.1021/acschembio.7b00903. Epub 2017 Dec 26.

DOI:10.1021/acschembio.7b00903
PMID:29202222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5778390/
Abstract

Pan-Assay Interference Compounds (PAINS) are very familiar to medicinal chemists who have spent time fruitlessly trying to optimize these nonprogressible compounds. Electronic filters formulated to recognize PAINS can process hundreds and thousands of compounds in seconds and are in widespread current use to identify PAINS in order to exclude them from further analysis. However, this practice is fraught with danger because such black box treatment is simplistic. Here, we outline for the first time all necessary considerations for the appropriate use of PAINS filters.

摘要

泛分析干扰化合物(PAINS)对于那些花费时间徒劳地试图优化这些无进展化合物的药物化学家来说并不陌生。为识别PAINS而设计的电子过滤器可以在几秒钟内处理成千上万种化合物,并且目前被广泛用于识别PAINS,以便将它们排除在进一步分析之外。然而,这种做法充满危险,因为这种黑箱处理过于简单化。在这里,我们首次概述了正确使用PAINS过滤器所需考虑的所有因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/7777b441d4bb/cb-2017-00903z_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/b6d060d20ac7/cb-2017-00903z_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/c9ad99505756/cb-2017-00903z_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/1e0be13b961a/cb-2017-00903z_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/cfe71a68adab/cb-2017-00903z_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/7777b441d4bb/cb-2017-00903z_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/b6d060d20ac7/cb-2017-00903z_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/c9ad99505756/cb-2017-00903z_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/1e0be13b961a/cb-2017-00903z_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/cfe71a68adab/cb-2017-00903z_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/5778390/7777b441d4bb/cb-2017-00903z_0004.jpg

相似文献

1
Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations.七年之痒:2017年的全面分析干扰化合物(PAINS)——效用与局限
ACS Chem Biol. 2018 Jan 19;13(1):36-44. doi: 10.1021/acschembio.7b00903. Epub 2017 Dec 26.
2
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.新型亚结构筛选器,可用于从筛选库中去除泛分析干扰化合物(PAINS),并在生物测定中对其进行排除。
J Med Chem. 2010 Apr 8;53(7):2719-40. doi: 10.1021/jm901137j.
3
Highly Promiscuous Small Molecules from Biological Screening Assays Include Many Pan-Assay Interference Compounds but Also Candidates for Polypharmacology.来自生物筛选试验的高度混杂小分子包含许多泛分析干扰化合物,但也有多重药理学的候选物。
J Med Chem. 2016 Nov 23;59(22):10285-10290. doi: 10.1021/acs.jmedchem.6b01314. Epub 2016 Nov 3.
4
Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS.幻痛:泛分析干扰化合物警报的效用问题
J Chem Inf Model. 2017 Mar 27;57(3):417-427. doi: 10.1021/acs.jcim.6b00465. Epub 2017 Feb 25.
5
How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds.泛分析干扰化合物的出现频率有多高?大规模筛选数据的分析揭示了多样化的活性特征、低的全球命中频率以及许多始终不活跃的化合物。
J Med Chem. 2017 May 11;60(9):3879-3886. doi: 10.1021/acs.jmedchem.7b00154. Epub 2017 Apr 25.
6
Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds.用少于 35 万种化合物实现对具有商业可用性的类铅筛选空间的广泛覆盖。
J Chem Inf Model. 2013 Jan 28;53(1):39-55. doi: 10.1021/ci300461a. Epub 2012 Dec 17.
7
Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.无实际痛苦的收获:“公平试验策略”在多靶点配体开发中的地位。
Acta Pharm Sin B. 2021 Nov;11(11):3417-3432. doi: 10.1016/j.apsb.2021.02.023. Epub 2021 Mar 4.
8
Exploring Activity Profiles of PAINS and Their Structural Context in Target-Ligand Complexes.探索 PAINS 的活性特征及其在靶标-配体复合物中的结构背景。
J Chem Inf Model. 2018 Sep 24;58(9):1847-1857. doi: 10.1021/acs.jcim.8b00385. Epub 2018 Aug 27.
9
Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter.机器学习能够高精度地区分具有混杂性或代表暗物质的泛分析干扰化合物。
J Med Chem. 2018 Nov 21;61(22):10255-10264. doi: 10.1021/acs.jmedchem.8b01404. Epub 2018 Nov 13.
10
Comment on The Ecstasy and Agony of Assay Interference Compounds.评分析干扰化合物的喜与忧
J Chem Inf Model. 2017 Nov 27;57(11):2640-2645. doi: 10.1021/acs.jcim.7b00313. Epub 2017 Nov 7.

引用本文的文献

1
Systematic characterization of cell type-specific master metabolic regulators in Alzheimer's disease.阿尔茨海默病中细胞类型特异性主要代谢调节因子的系统表征
Res Sq. 2025 Aug 18:rs.3.rs-7207381. doi: 10.21203/rs.3.rs-7207381/v1.
2
From code to cure: computational identification of LasR inhibitors to combat quorum sensing in P. aeruginosa.从编码到治愈:通过计算方法鉴定LasR抑制剂以对抗铜绿假单胞菌中的群体感应
Mol Divers. 2025 Aug 30. doi: 10.1007/s11030-025-11333-0.
3
In Silico ADME Methods Used in the Evaluation of Natural Products.用于天然产物评估的计算机辅助ADME方法

本文引用的文献

1
Comment on The Ecstasy and Agony of Assay Interference Compounds.评分析干扰化合物的喜与忧
J Chem Inf Model. 2017 Nov 27;57(11):2640-2645. doi: 10.1021/acs.jcim.7b00313. Epub 2017 Nov 7.
2
Privileged Structures Revisited.特权结构再探。
Angew Chem Int Ed Engl. 2017 Jun 26;56(27):7971-7974. doi: 10.1002/anie.201702816. Epub 2017 May 30.
3
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
Pharmaceutics. 2025 Jul 31;17(8):1002. doi: 10.3390/pharmaceutics17081002.
4
Cell type-specific master metabolic regulators of Alzheimer's disease.阿尔茨海默病的细胞类型特异性主要代谢调节因子。
bioRxiv. 2025 Jul 17:2025.07.11.664443. doi: 10.1101/2025.07.11.664443.
5
Assay2Mol: large language model-based drug design using BioAssay context.分析到分子:基于大语言模型并利用生物分析背景的药物设计
ArXiv. 2025 Jul 16:arXiv:2507.12574v1.
6
N'-(1-phenylethylidene)-benzohydrazide cytotoxicity is LSD1 independent and linked to Fe-S cluster disruption in Ewing sarcoma.N'-(1-苯基亚乙基)-苯甲酰肼的细胞毒性不依赖赖氨酸特异性去甲基化酶1(LSD1),且与尤因肉瘤中的铁硫簇破坏有关。
bioRxiv. 2025 Jun 26:2025.06.20.660795. doi: 10.1101/2025.06.20.660795.
7
Pegylation approach applied to erlotinib-carbonic anhydrase inhibitors hybrids towards anticancer agents.聚乙二醇化方法应用于厄洛替尼-碳酸酐酶抑制剂杂合物以制备抗癌剂。
RSC Med Chem. 2025 Apr 28. doi: 10.1039/d5md00109a.
8
A dynamic scapping workflow for RTK domains: computational modeling of natural products as dual modulators of EGFR and VEGFR signaling in breast cancer.一种用于受体酪氨酸激酶(RTK)结构域的动态筛选工作流程:天然产物作为乳腺癌中表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR)信号传导双重调节剂的计算建模
Mol Divers. 2025 Jul 10. doi: 10.1007/s11030-025-11263-x.
9
Exploration of effective pharmacological inhibitors for NS5 protein through computational approach: A strategy to combat the neglected Kyasanur forest disease virus.通过计算方法探索NS5蛋白的有效药理抑制剂:对抗被忽视的基孔肯雅森林病病毒的策略
PLoS One. 2025 Jul 10;20(7):e0325613. doi: 10.1371/journal.pone.0325613. eCollection 2025.
10
Identification of chemical scaffolds for targeting ubiquitin-specific protease 11 (USP11) through high-throughput virtual screening.通过高通量虚拟筛选鉴定靶向泛素特异性蛋白酶11(USP11)的化学骨架
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2518191. doi: 10.1080/14756366.2025.2518191. Epub 2025 Jun 30.
ACS Med Chem Lett. 2017 Feb 28;8(4):379-382. doi: 10.1021/acsmedchemlett.7b00056. eCollection 2017 Apr 13.
4
How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds.泛分析干扰化合物的出现频率有多高?大规模筛选数据的分析揭示了多样化的活性特征、低的全球命中频率以及许多始终不活跃的化合物。
J Med Chem. 2017 May 11;60(9):3879-3886. doi: 10.1021/acs.jmedchem.7b00154. Epub 2017 Apr 25.
5
Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS.幻痛:泛分析干扰化合物警报的效用问题
J Chem Inf Model. 2017 Mar 27;57(3):417-427. doi: 10.1021/acs.jcim.6b00465. Epub 2017 Feb 25.
6
PubChem BioAssay: 2017 update.《PubChem生物测定:2017年更新》
Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. doi: 10.1093/nar/gkw1118. Epub 2016 Nov 29.
7
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib.针对聚(ADP-核糖)糖苷水解酶(PARG)的首创化学探针以与奥拉帕尼不同的药理学抑制DNA修复。
ACS Chem Biol. 2016 Nov 18;11(11):3179-3190. doi: 10.1021/acschembio.6b00609. Epub 2016 Oct 12.
8
KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries.用于评估SMARTS格式PAINS过滤器的KNIME工作流程。RDKit和Indigo化学信息学库的比较。
Mol Inform. 2011 Oct;30(10):847-50. doi: 10.1002/minf.201100076. Epub 2011 Aug 4.
9
Badapple: promiscuity patterns from noisy evidence.《坏苹果:来自嘈杂证据的滥交模式》
J Cheminform. 2016 May 28;8:29. doi: 10.1186/s13321-016-0137-3. eCollection 2016.
10
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).感受大自然的“痛点”:天然产物、天然产物药物与泛分析干扰化合物(PAINS)
J Nat Prod. 2016 Mar 25;79(3):616-28. doi: 10.1021/acs.jnatprod.5b00947. Epub 2016 Feb 22.